Prelude Capital Management’s Dyne Therapeutics DYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.1M Buy
115,765
+23,113
+25% +$220K 0.11% 233
2025
Q1
$969K Buy
+92,652
New +$969K 0.07% 261